The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

Over the past 13 years bone marrow‐derived mononuclear cells (BM‐MNCs) have been widely investigated for clinical efficacy in patients following acute myocardial infarction (AMI). These early phase II trials have used various surrogate markers to judge efficacy and, although promising, the results h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of heart failure 2017-11, Vol.19 (11), p.1545-1550
Hauptverfasser:	Mathur, Anthony, Arnold, Roman, Assmus, Birgit, Bartunek, Jozef, Belmans, Ann, Bönig, Halvard, Crea, Filippo, Dimmeler, Stefanie, Dowlut, Sheik, Fernández‐Avilés, Francisco, Galiñanes, Manuel, Garcia‐Dorado, David, Hartikainen, Juha, Hill, Jonathan, Hogardt‐Noll, Annette, Homsy, Christian, Janssens, Stefan, Kala, Petr, Kastrup, Jens, Martin, John, Menasche, Philippe, Miklik, Roman, Mozid, Abdul, San Román, J. Alberto, Sanz‐Ruiz, Ricardo, Tendera, Michal, Wojakowski, Wojtek, Ylä‐Herttuala, Seppo, Zeiher, Andreas
Format:	Artikel
Sprache:	eng
Schlagworte:	BAMI Bone Marrow Transplantation - methods Bone marrow‐derived mononuclear cells Cardiac regeneration Cardiovascular disease Cause of Death - trends Cell therapy Echocardiography Europe - epidemiology Female Heart failure Humans Male Myocardial infarction New Treatments ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - mortality ST Elevation Myocardial Infarction - therapy Study Design Survival Rate - trends Treatment Outcome Ventricular Function, Left - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!